Skip to content
Thursday, July 16, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • This clown eats bubbles, cracks jokes and helps Israeli children recover from trauma July 16, 2026
  • Inside America’s first prison synagogue, a new exhibit tells the story of Jewish inmates who built it July 16, 2026
  • From Einstein’s $500 Bond to $57 Billion in Israel Bonds July 15, 2026
  • ADL and JCPA diverge over teachers union, exposing a divide over how to fight antisemitism July 15, 2026
  • AOC urges Clavicular, who visited Tel Aviv, to ‘shed some light’ on the plight of the Palestinians July 15, 2026
  • The Kristallnacht Monument and the Question of Whether to Stop July 15, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.